Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Total article views   HTML views PDF downloads Totals
4,916 Dovepress* 4,526+ 949 5,475
PubMed Central* 390 108 498
Totals 4,916 1,057 5,973
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar